Sowell Financial Services LLC Bio N Tech Se Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$113.32 - $241.49 $36,489 - $77,759	-322 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$85.73 - $119.5 $3,600 - $5,019	42 Added 15.0%	322 $54,000
Q4 2020 Jan 13, 2021	SELL	$72.71 - $129.54 $9,379 - $16,710	-129 Reduced 31.54%	280 $23,000
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $6,301 - $11,354	109 Added 36.33%	409 $28,000
Q2 2020 Aug 13, 2020	BUY	$38.58 - $66.74 $11,188 - $19,354	290 Added 2900.0%	300 $20,000
Q1 2020 May 12, 2020	BUY	$28.55 - $92.0 $285 - $920	10 New	10 $1,000

362

39.7M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.